Glaxo faces investigation into alleged corruption in China
Executives 'confessed' to offering bribes to officials to raise the price of medicines
Senior executives at Britain's biggest drug maker, GlaxoSmithKline, are facing a criminal investigation in China for allegedly bribing officials as the company stands accused of being at the centre of a "huge" scheme to raise drug prices in the country.
The Ministry of Public Security claimed the executives had confessed, under interrogation by Chinese officials, to handing government workers and hospital personnel cash and perks for prescribing medications.
It said an investigation in three of the country's biggest cities, Shanghai, Changsha and Zhengzhou, had found that GSK tried to increase medicine prices by bribing doctors, hospitals, government officials and pharmaceutical industry associations.
The ministry said GSK executives had admitted to paying and accepting bribes via conference rebates and project fees. "After initial questioning, the suspects have admitted to the crimes and the investigation is ongoing," it said.
The claims could be a major blow for the FTSE 100 drugs giant, which has been pushing its Chinese business for major growth as key medicines fall out of patent in the West. Glaxo earned £875m from China in 2012, and has five manufacturing plants in the country, employing 5,000.
A spokesman for GSK said the public statement was the first it had heard of the allegations. He added that the company was "willing to co-operate with the authorities in this inquiry".
He said: "We take all allegations of bribery and corruption seriously. We continuously monitor our businesses to ensure they meet our strict compliance procedures. We have done this in China and found no evidence of bribery or corruption of doctors or government officials. However, if evidence of such activity is provided, we will act swiftly on it."
GSK has faced heavy scrutiny of its work in China on several fronts this week. Officials in Beijing are investigating potential price-fixing by GSK and other drug makers, including its rivals Merck, Novartis and Baxter.
They faced claims that its staff used improper tactics to market Botox in China. GSK said it had found "no evidence to support allegations" that staff handed doctors cash and other kickbacks for prescribing Botox.
'Gifts' that carry risks
On a trip to Hong Kong last year, I had dinner with a bunch of high-flying legal expats who told me how business is done across China.
How to accept a business card (two hands, look very excited), the imperativeness of small talk – and the huge importance of gifts. "They're part of how we do business," I was told.
Nowhere are those gifts more important in China than in its healthcare system, where doctors' low salaries are topped up by payments from patients and bribes from equipment-makers and drug suppliers. There are big prizes for cracking China – which drug makers need as Western markets flatten – but major risks too.
Just ask the Australian citizen Stern Hu and the other ex-Rio Tinto employees currently languishing in Chinese prisons after being charged with taking bribes. Hu was sentenced to a decade in a shared cell, sleeping on communal wooden boards.
- 1 Paris attacks: Do not call Charlie Hebdo killers 'terrorists', BBC says
- 2 Man who held up 'hire me' sign at Waterloo station returns a year later with 'I'm hiring' sign
- 3 UK weather: Snow to fall in the coming week with sub-zero temperatures to last until early February
- 4 Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
- 5 The enemy within: People who hear voices in their heads are being encouraged to talk back
Paris attacks: Do not call Charlie Hebdo killers 'terrorists', BBC says
Rowan Atkinson to sell £10 million McLaren 'supercar' he crashed into a tree and a lamppost
UK weather: Snow to fall in the coming week with sub-zero temperatures to last until early February
Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
Howard 'Mr Nice' Marks reveals he has inoperable cancer: 'I've had an incredible life'
Nigel Farage: NHS might have to be replaced by private health insurance
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
French court convicts three over homophobic tweets, in case hailed as a 'significant victory' by LGBT rights campaigners
Greece elections: Syriza and EU on collision course after election win for left-wing party
British Muslim school children suffering a backlash of abuse following Paris attacks
George Galloway condemns 'racist, Islamophobic, hypocritical rag' Charlie Hebdo at freedom of speech rally
iJobs Money & Business
£30000 - £32000 per annum + benefits : Ashdown Group: A highly successful, int...
£18000 - £20000 per annum: Recruitment Genius: This rapidly expanding business...
£25 - 28k + Bonus: Guru Careers: An In-house / Internal Recruiter is needed to...
Negotiable: Recruitment Genius: A Tax Assistant is required to join a leading ...